acetazolamide has been researched along with Bowel Diseases, Inflammatory in 1 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 238 IBD patients; 116 Crohn's disease (CD) and 122 ulcerative colitis (UC), besides 197 healthy controls were included in this study." | 1.37 | Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease. ( Akin, H; Atuğ, O; Eren, F; Hamzaoglu, HO; Hamzaoğlu, I; Imeryüz, N; Tahan, G; Tahan, V; Tözün, N; Türe, F, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akin, H | 1 |
| Tahan, G | 1 |
| Türe, F | 1 |
| Eren, F | 1 |
| Atuğ, O | 1 |
| Tahan, V | 1 |
| Hamzaoğlu, I | 1 |
| Imeryüz, N | 1 |
| Tözün, N | 1 |
| Hamzaoglu, HO | 1 |
1 other study available for acetazolamide and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease.
Topics: Acetazolamide; Adolescent; Adult; Aged; Aged, 80 and over; Antimicrobial Cationic Peptides; Blood Pr | 2011 |